Search Results 1021-1030 of 13323 for monoclonal antibody
Lenalidomide In Improving Immune Response To Vaccine Therapy In Patients With Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Or Monoclonal B Cell ...
... monoclonal antibody (eg.daratumumab or isatuximab) - Prior non-belantamab mafodotin anti-BCMA agent exposure is allowed; patients with prior treatment with ...
... monoclonal antibody targeting MISIIR. Oncotarget. 2017 Oct 17; 8 (49):85214-85223 Epub 2017 July 27. View PubMed; Murphy BL, Glasgow AE, Keeney GL, Habermann ...
... antibody, myelin oligodendrocyte glycoprotein — also known as MOG, and an increased risk of recurring attacks in these individuals. Mayo Clinic neurologists ...
Clinical Trials · A Study Of Atezolizumab (Anti-Programmed Death-Ligand 1 [PD-L1] Antibody) In Combination With Carboplatin Plus (+) Nab-Paclitaxel Compared With ...
Monoclonal antibody treatment for COVID-19 in solid organ transplant recipients. Transpl Infect Dis. 2022 Feb; 24 (1):e13759 Epub 2021 Dec 07. View PubMed ...
... Monoclonal Antibody Screening Score. Mayo Clin Proc Innov Qual Outcomes. 2023 Apr; 7 (2):109-121 Epub 2023 Jan 11. View PubMed; Shah SZ, Alvarez FG, Sanghavi ...
Monoclonal antibodies, such as bevacizumab, can block tumor growth in different ways. Some block the ability of tumor cells to grow and spread. Others find ...
Dinutuximab is a monoclonal antibody that binds to a molecule called GD2 ... Monoclonal antibodies, such as bevacizumab, can block tumor growth in different ways.
Monoclonal antibody within 4 weeks. Not recovered from toxicity of any prior chemotherapy to grade ≤ 1. History of other active malignancies within 2 years ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.